Showing results (1971-1980 of 3,160) with videos related to

Sort By:
Pageof 316
Neuro-Oncology|March 4, 2010
Genetic variations in EGF and EGFR and glioblastoma outcomeSara Sjöström, Ulrika Andersson, Yanhong Liu, et al.
Neuro-Oncology|March 5, 2010
Expression of hepatocyte growth factor and its receptor c-Met in human pituitary adenomasXian-Zeng Hou, Wei Liu, Hai-Tao Fan, et al.
Neuro-Oncology|September 14, 2014
Suppression of miR-184 in malignant gliomas upregulates SND1 and promotes tumor aggressivenessLuni Emdad, Aleksandar Janjic, Mohammad A Alzubi, et al.
Neuro-Oncology|September 18, 2014
Relationships between tumor grade and neurocognitive functioning in patients with glioma of the left temporal lobe prior to surgical resectionKyle R Noll, Catherine Sullaway, Mateo Ziu, et al.
Neuro-Oncology|January 9, 2015
Combining progression-free survival and overall survival as a novel composite endpoint for glioblastoma trialsLorenzo Trippa, Patrick Y Wen, Giovanni Parmigiani, et al.
Neuro-Oncology|November 15, 2014
Subsequent neoplasms in survivors of childhood central nervous system tumors: risk after modern multimodal therapyKaren Tsui, Amar Gajjar, Chenghong Li, et al.
Neuro-Oncology|October 25, 2014
Epidermal growth factor receptor and variant III targeted immunotherapyKendra L Congdon, Patrick C Gedeon, Carter M Suryadevara, et al.
Neuro-Oncology|August 20, 2017
Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumorsXuling Lin, Martin Fleisher, Marc Rosenblum, et al.
Neuro-Oncology|October 19, 2017
Radiation-induced cognitive toxicity: pathophysiology and interventions to reduce toxicity in adultsChristopher Wilke, David Grosshans, Joseph Duman, et al.
Neuro-Oncology|October 17, 2017
CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomideSimran Kaur, Zubaidah M Ramdzan, Marie-Christine Guiot, et al.
Pageof 316